Shattuck Labs (STTK) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for Shattuck Labs
Is Shattuck Labs a buy right now? The alternative data says hold. This STTK stock analysis is built on the 25+ alternative data signals AltIndex tracks on Shattuck Labs every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 49/100: a Hold. The stock trades at $6.79 with a $694M market cap.
The data leans positive over the past 90 days — web traffic up 17.9% to 6K monthly visits, headcount (according to LinkedIn) up 16.3% to 57 employees, and 79% of employees are positive on the business outlook — but the move hasn’t been broad enough to lift STTK into buy territory yet.
STTK’s broader alt-data profile also covers job postings (1 open roles), and sentiment (100/100). Every signal links to its own page with full history, the STTK technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on STTK is just below.
Shattuck Labs AI Stock Analysis
Shattuck Labs is a clinical-stage biotechnology company focused on developing novel treatments for cancer and autoimmune diseases. The company's primary product candidates are based on its dual-sided fusion protein platform. Leveraging cutting-edge science, Shattuck Labs aims to create therapies that offer potent and differentiated mechanisms of action.
Analysis generated September 1, 2026.
Recent Shattuck Labs Stock Alerts
|
Shattuck Labs | August 28 Price is down by -6% in the last 24h. |
|
Shattuck Labs | August 24 Price is up by 6.1% in the last 24h. |
|
Shattuck Labs | August 12 Price is up by 6.1% in the last 24h. |
|
Shattuck Labs | August 5 Price is down by -6.1% in the last 24h. |
Shattuck Labs Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 6K | 17.9% | |
| Job Posts | 1 | 0% | |
| LinkedIn Employees | 57 | 16.3% | |
| Employee Recommend | 96 | 0% | |
| Business Outlook | 79 | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 75.0% | |
| Stocktwits Mentions | 0 | 100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 660 | 2.8% | |
| 4chan Mentions | 0 | N/A |
About Shattuck Labs (STTK)
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.
| Price | $6.79 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $694M |
| Year Range | $2 – $8 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Shattuck Labs News
View more → |
Why Shattuck Labs Stock Flew Nearly 5% Higher on FridayJuly 24 - Biztoc.com |
Shattuck Labs, Inc. Announces Pricing of $75 Million Public OfferingJune 9 - GlobeNewswire |
|
Shattuck Labs, Inc. Announces Proposed Public OfferingJune 9 - GlobeNewswire |
|
Shattuck Labs Announces Phase 1 Results for SL-325June 8 - GlobeNewswire |
|
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8June 5 - GlobeNewswire |
See Shattuck Labs’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for STTK, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEShattuck Labs Earnings & Financial Performance
View all earnings →Shattuck Labs Insider Trading Activity
View all →| Shukla Abhinav A. filed to sell 86,380 shares at $0.0. Jul 2 '26 |
| Shukla Abhinav A. filed to sell 86,380 shares at $0.0. Jul 1 '26 |
| Pandite Arundathy N. filed to sell 136,219 shares at $0.0. Jun 30 '26 |
| Shukla Abhinav A. filed to sell 86,380 shares at $0.0. Jun 30 '26 |
| ORBIMED ADVISORS LLC filed to sell 5,303,908 shares at $0.0. Jun 11 '26 |
Shattuck Labs Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Shattuck Labs
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Bright Minds BiosciencesDRUG |
$65.16 4.2% | $698M | 54 |
 |
Allogene TherapeuticsALLO |
$1.97 0.5% | $686M | 50 |
 |
Gyre TherapeuticsGYRE |
$6.86 6.5% | $683M | 43 |
 |
Sophia Genetics SASOPH |
$8.09 2.5% | $705M | 49 |
 |
Sagimet BiosciencesSGMT |
$10.94 0.2% | $679M | 53 |
Explore Shattuck Labs Data
Frequently Asked Questions: Shattuck Labs (STTK)
Shattuck Labs has an AltIndex AI Score of 49/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
49/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Shattuck Labs (STTK) stock is $6.79 with a market cap of $694M.
As of today, Shattuck Labs’s PE (Price to Earnings) ratio is —.
View the latest Shattuck Labs insider transactions to see recent buying and selling activity by company executives and directors.
Check the Shattuck Labs congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The STTK stock price chart above shows Shattuck Labs’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Shattuck Labs technical analysis for RSI, moving averages, and more.
See the stocks similar to Shattuck Labs section on this page for companies in the same industry ranked by market cap and AI Score.
